Clinical news
Every clinical development we have covered, newest first.
Direct answer
1 dated clinical item. Most recent: Retatrutide reaches 30.3% weight loss in Phase 3 (2026-08-04).
For context: across 32 tracked tirzepatide telehealth programmes, 17 publish a price we could capture, and the cheapest verified all-in cost is $215 a month at a 10 mg maintenance dose — about $2,580 for a first year. Compounded preparations are not FDA-approved. Prices captured 2026-08-05.
All-in monthly cost at 10 mg
Stories in this category
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.